NCT07611448
Blastocyst AI Assisted Morphokinetics in ART
Enrolling by Invitation
Not specifiedAges 18–45ObservationalViable Biosciences
~1,000 participants
Updated 2026-05-28 on ClinicalTrials.gov
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Ongoing Clinical Pregnancy
Measured over From enrollment and embryo morphokinetic evaluation to ongoing clinical pregnancy evaluated at 12 weeks of pregnancy in pregnant patients.
Conditions
Where it's being run
1 sites across 1 statesCalifornia1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Signed Inform Consent
Ages between 18 and 45 years
Patients using own or donated eggs
Patients undergoing assisted reproduction procedures (ICSI with Embryo Transfer, Frozen Embryo Transfers with or without PGT-A receiving a single embryo transfer.
Patients with at least one embryo at the blastocyst stage on day 5, day 6 or day 7 of embryo development.
Patients using a surrogate carrier for the embryo transfer procedure.
Patients with Abnormal Embryos after PGT-A to be discarded.
Patients with Euploid Embryos after PGT-A to be discarded
Exclusion
Absence of viable embryos at the blastocyst stage.
Any uterine abnormalities that could affect embryo implantation.
What this trial measures
- Ongoing Clinical PregnancyFrom enrollment and embryo morphokinetic evaluation to ongoing clinical pregnancy evaluated at 12 weeks of pregnancy in pregnant patients.
Evaluate the association between the AI assisted blastocyst Morphokinetic extracted from a 30 seconds blastocyst video recording and ongoing clinical pregnancy.